Role of ^18F-FDG PET Scans in Patients with Helicobacter pylori-Infected Gastric Low-Grade MALT Lymphoma
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Endoscopic ultrasound (EUS) plays a crucial role in the assessment and treatment of low-grade gastric mucosa-associated lymphoid tissue (MALT) lymphoma; however, interobserver variation, inadequate accuracy in judging the depth of tumor invasion, and histological heterogeneity of the tumor can limit its role. Thus, we have assessed the role of ^18F-FDG PET scans in the management of Helicobacter pylori-infected gastric MALT lymphoma. Methods: Eighteen patients with H. pylori-infected low-grade gastric MALT lymphoma underwent an ^18F-FDG PET scan prior to receiving H. pylori eradication therapy. We analyzed these patients’ clinicopathologic data and measured the baseline and change in the metabolic activity of the tumor using standardized uptake values (SUVs). Results: Two patients failed to achieve complete remission of the low-grade gastric MALT lymphoma after successful H. pylori eradication. The baseline SUVs were significantly higher in these patients compared to successfully treated patients, 13.35±0.07 vs 2.98±0.93, respectively (n=2 vs n=16, p<0.001). The reduction in the SUV was significantly greater in the complete remission patients compared to treatment failure patients (p=0.018). Conclusions: A high SUV at baseline ^18F-FDG PET and a lower reduction in the SUV within 3 months after eradication therapy are associated with treatment failure in H. pylori-positive low-grade gastric MALT lymphoma patients undergoing eradication treatment.
Abstract
Background/Aims: Endoscopic ultrasound (EUS) plays a crucial role in the assessment and treatment of low-grade gastric mucosa-associated lymphoid tissue (MALT) lymphoma; however, interobserver variation, inadequate accuracy in judging the depth of tumor invasion, and histological heterogeneity of the tumor can limit its role. Thus, we have assessed the role of ^18F-FDG PET scans in the management of Helicobacter pylori-infected gastric MALT lymphoma. Methods: Eighteen patients with H. pylori-infected low-grade gastric MALT lymphoma underwent an ^18F-FDG PET scan prior to receiving H. pylori eradication therapy. We analyzed these patients’ clinicopathologic data and measured the baseline and change in the metabolic activity of the tumor using standardized uptake values (SUVs). Results: Two patients failed to achieve complete remission of the low-grade gastric MALT lymphoma after successful H. pylori eradication. The baseline SUVs were significantly higher in these patients compared to successfully treated patients, 13.35±0.07 vs 2.98±0.93, respectively (n=2 vs n=16, p<0.001). The reduction in the SUV was significantly greater in the complete remission patients compared to treatment failure patients (p=0.018). Conclusions: A high SUV at baseline ^18F-FDG PET and a lower reduction in the SUV within 3 months after eradication therapy are associated with treatment failure in H. pylori-positive low-grade gastric MALT lymphoma patients undergoing eradication treatment.
참고문헌 (23)
- Suzuki H, "Helicobacter pylori: present status and future prospects in Japan", J Gastroenterol, 42, pp.1~15 (2007)
- Stolte M, "Helicobacter and gastric MALT lymphoma", Gut, 50(Suppl 3), pp.III19~III24 (2002)
- Steinbach G, "Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue: an uncontrolled trial", Ann Intern Med, 131, pp.88~95 (1999)
- Ruskoné-Fourmestraux A, "Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment", Gut, 48, pp.297~303 (2001)
- Alpen B, "Translocation t(11;18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication of Helicobacter pylori infection", Blood, 95, pp.4014~4015 (2000)
- Fusaroli P, "Interobserver agreement in staging gastric malt lymphoma by EUS", Gastrointest Endosc, 55, pp.662~668 (2002)
- Ferreri AJ, "Ponzoni M. Prognostic significance of the histopathologic recognition of low- and high-grade components in stage I-II B-cell gastric lymphomas", Am J Surg Pathol, 25, pp.95~102 (2001)
- Harris NL, "World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997", J Clin Oncol, 17, pp.3835~3849 (1999)
- Chan JK, "Gastrointestinal lymphomas: an overview with emphasis on new findings and diagnostic problems", Semin Diagn Pathol, 13, pp.260~296 (1996)
- Hsi ED, "Classification of primary gastric lymphomas according to histologic features", Am J Surg Pathol, 22, pp.17~27 (1998)
- Weber WA, "Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging", J Clin Oncol, 19, pp.3058~3065 (2001)
- Kostakoglu L, "PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus", J Nucl Med, 45, pp.56~68 (2004)
- Kostakoglu L, "18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma", J Nucl Med, 44, pp.224~239 (2003)
- Beal KP, "FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases", Ann Oncol, 16, pp.473~480 (2005)
- Hoffmann M, "18F-Fluoro-deoxy-glucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: histology makes the difference", Ann Oncol, 17, pp.1761~1765 (2006)
- Ambrosini V, "Diagnostic role of 18F-FDG PET in gastric MALT lymphoma", Nucl Med Rev Cent East Eur, 9, pp.37~40 (2006)
- El-Zahabi LM, "The value of EUS in predicting the response of gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication", Gastrointest Endosc, 65, pp.89~96 (2007)
- Sackmann M, "Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group", Gastroenterology, 113, pp.1087~1090 (1997)
- Wotherspoon AC, "Low-grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue (MALT): a multifocal disease", Histopathology, 20, pp.29~34 (1992)
- Weber WA, "Thödtmann R, Hanauske AR, Schwaiger M. Reproducibility of metabolic measurements in malignant tumors using FDG PET", J Nucl Med, 40, pp.1771~1777 (1999)
- Chen LT, "Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach", J Clin Oncol, 19, pp.4245~4251 (2001)
- Chen LT, "Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma", J Natl Cancer Inst, 97, pp.1345~1353 (2005)
- Yohsuke Makino, "Ileal Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma with a Large-Cell Component That Regressed Spontaneously", Gut and Liver, 4(1), pp.117~121 (2010), 거트앤리버 발행위원회